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Extracellular purines are important signalling molecules in the
vasculature that are regulated by a network of cell surface
ectoenzymes. By using human endothelial cells and normal and
leukaemic lymphocytes as enzyme sources, we identified the
following purine-converting ectoenzymes: (1) ecto-nucleotidases,
NTP diphosphohydrolase}CD39 (EC 3.6.1.5) and ecto-5«-
nucleotidase}CD73 (EC 3.1.3.5) ; (2) ecto-nucleotide kinases,
adenylate kinase (EC 2.7.4.3) and nucleoside diphosphate kinase
(EC2.7.4.6) ; (3) ecto-adenosine deaminase (EC3.5.4.4). Evidence
for this was obtained by using enzyme assays with $H-labelled
nucleotides and adenosine as substrates, direct evaluation of γ-
phosphate transfer from [γ-$#P]ATP to AMP}NDP, and bio-
luminescent measurement of extracellular ATP synthesis. In
addition, incorporation of radioactivity into an approx. 20 kDa
surface protein was observed following incubation of Namalwa
B cells with [γ-$#P]ATP. Thus two opposite, ATP-generating and
ATP-consuming, pathways coexist on the cell surface, where
INTRODUCTION
Important roles for extracellular purines as key signalling
molecules have been established in several tissues, including the
cardiovascular system, where they mediate both inflammatory
(ATP, ADP) and anti-inflammatory (adenosine) effects. The
appearance of nucleotides in the external milieu represents a
critical component of the signalling cascades, and the proposed
mechanisms include ATP}ADP efflux through the opening of
channel-like pathways, vesicular exocytosis and cell lysis during
organ injury [1]. Once released, ATP and}or ADP regulate
hemostasis and thrombosis via activation and aggregation of
platelets at sites of vascular injury [2] and mediate several
inflammatory responses, including the release of the cytokines,
tumour necrosis factor-α and interleukin-1β from monocytes}
macrophages, and facilitation of leucocyte adhesion to the
endothelium [1,3–5]. Most of these effects are mediated through
G-protein-coupled P2Y receptors as well as via ‘cytolytic ’ P2X
(
and other P2X receptors with intrinsic pore-forming activity
[4,6,7]. The duration and magnitude of purinergic signalling is
governed by nucleotide-degrading ectoenzymes. Currently
known nucleotidases include members of the E-type NTP
diphosphohydrolase (NTPDase) family, ecto-nucleotide pyro-
phosphatase}phosphodiesterase family, alkaline phosphatases
and ecto-5«-nucleotidase. All of them have a broad tissue
distribution [8,9].
Adenosine is an important intermediate of purine nucleotide
metabolism with effects that are often opposite to ATP. Par-
ticularly, adenosine has protective effects on ischaemia-induced
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antibody; NBTI, nitrobenzylthioinosine ; NTPDase, NTP diphosphohydrolase; PBL, peripheral blood lymphocytes ; PI-PLC, phosphatidylinositol-specific
phospholipase C.
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basal ATP release, re-synthesis of high-energy phosphoryls, and
selective ecto-protein phosphorylation are counteracted by step-
wise nucleotide breakdown with subsequent adenosine in-
activation. The comparative measurements of enzymic activities
indicated the predominance of the nucleotide-inactivating path-
way via ecto-nucleotidase reactions on the endothelial cells. The
lymphocytes are characterized by counteracting ATP-
regenerating}adenosine-eliminating phenotypes, thus allowing
them to avoid the lymphotoxic effects of adenosine and maintain
surrounding ATP at a steady-state level. These results are in
agreement with divergent effects of ATP and adenosine on
endothelial function and haemostasis, and provide a novel regul-
atory mechanism of local agonist availability for nucleotide- or
nucleoside-selective receptors within the vasculature.
Key words: ecto-adenosine deaminase, ecto-nucleotidase, ecto-
nucleotide kinase, purine metabolism.
endothelial injury, maintains endothelial barrier function,
supports vasodilatation and suppresses leucocyte adhesion to the
vascular endothelium [10–12]. These anti-inflammatory effects
are realized through G
s
-protein-coupled adenosine receptors [6]
with a non-redundant role of the cAMP-elevating A2a receptor
[12]. Subsequent to signal transduction, adenosine can be trans-
ported into the cell by equilibrative or Na+-dependent nucleoside
transporters to replenish the intracellular nucleotide pool [13].
Whereas most of the current models have focused on nucleotide
release, signalling and degradation}inactivation aspects, the
alternative pathways have received little attention. These mech-
anisms may include reverse nucleotide transphosphorylation by
ecto-nucleotide kinases [14–16] and ATP-mediated protein
phosphorylation via ecto-protein kinase reaction [17]. In the
present study, we performed a comprehensive biochemical analy-
sis of the major purine-converting activities on endothelial and
lymphoid cells, including: (i) nucleotide dephosphorylation to
adenosine; (ii) further adenosine deamination; (iii) reverse ATP
re-synthesis ; and (iv) ecto-protein phosphorylation. These
findings, in conjunction with constitutive ATP release, provide a
novel insight into the regulatory mechanisms of local agonist
availability for nucleotide- or nucleoside-selective receptors in
the bloodstream.
EXPERIMENTAL
Cell isolation and treatment
Human umbilical vein endothelial cells (HUVEC) were isolated
from fresh umbilical cords as described previously [15]. The B-
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cell lymphoma line Namalwa and human leukaemic T-cell
lymphoblast line Jurkat were obtained from A.T.C.C. (Manassas,
VA, U.S.A.) and maintained in RPMI 1640 medium
supplemented with 10% foetal calf serum, 4 mM -glutamine,
100 units}ml penicillin and 100 µg}ml streptomycin. Peripheral
blood lymphocytes (PBL) were isolated from freshly drawn
donor blood using Ficoll centrifugations.
Prior to the experiments, HUVEC (passages 2 and 3) and
lymphocytes were washed with RPMI 1640 and incubated with
exogenous purines as a suspension of either intact or disrupted
cells. Disruption of the cells was achieved by sonication on ice for
30 s at medium power (Braun sonicator Labsonic U). In some
experiments, the cells were pre-incubated for 30 min at 37 °C
with soluble apyrase from potato (grade III, 2 units}ml) or
recombinant phosphatidylinositol-specific phospholipase C (PI-
PLC) from Bacillus thuringiensis (0.5 unit}ml), and then washed
twice with RPMI 1640. The integrity and viability of the cells at
the end of experiments were confirmed by light-microscopy
observations with a Trypan Blue-exclusion test, and at least 95%
of the cells remained viable after 60–80 min incubation in RPMI
1640 medium at 37 °C. Similar results were obtained by using
propidium iodine staining followed by flow-cytometric analysis.
Interconversion of 3H-labelled nucleotides and adenosine
Nucleotide-converting activities were assayed by TLC with [2,8-
$H]ATP (specific radioactivity 19 Ci}mmol; Sigma), [2,8-$H]ADP
(25.3 Ci}mmol; Sigma) and [2-$H]AMP (18.6 Ci}mmol;
Amersham) as appropriate substrates. The standard enzyme
assay contained, in a final volume of 120 µl of RPMI 1640,
(3–5)¬10% cells, 5 mmol}l β-glycerophosphate, the indicated
concentrations of the substrate with tracer $H-nucleotide
(approx. 4¬10& d.p.m.) and γ-phosphate-donating ATP}NTP
(in the case of nucleotide kinase studies). Incubation times were
chosen to ensure the linearity of the reaction with time, so that
the amount of the converted nucleotides did not exceed 7–10%
of the initially introduced substrate. Aliquots of the mixture were
applied on to Alugram SIL G}UV
#&%
TLC sheets (Macherey-
Nagel, Du$ ren, Germany) and separated with 2-methylpropan-1-
ol}3-methylbutan-1-ol}2-ethoxyethanol}ammonia}water
(3:2 :6 :3 :5, by vol.) as a solvent [18]. $H-labelled substrates and
their derivatives were visualized in UV light and quantified using
a Wallac-1409 β-spectrometer, as described previously [19]. A
similar approach was applied for the measurement of adenosine
deaminase, where cell suspensions were incubated with [2-
$H]adenosine (24 Ci}mmol; Amersham), followed by separation
of $H-nucleosides with 2-methylpropan-1-ol}ethyl acetate}
methanol}ammonia (7:4 :3 :4, by vol.) [20].
Flow-cytometric analysis
Endothelial and lymphoid cells were stained by immuno-
fluorescence with anti-CD73 monoclonal antibody (mAb) 4G4
or isotype-specific mAb 3G6 as a negative control [21]. The
cells were then incubated with FITC-conjugated anti-mouse Ig
(Dako, Carpinteria, Glostrup, Denmark) and analysed using an
FACScan with Cell Quest software (Becton Dickinson, CA,
U.S.A.).
Transphosphorylation of [γ-32P]ATP with AMP/NDP and protein
phosphorylation
The cells were incubated for 5 min at 37 °C in a final volume of
60 µl of RPMI 1640, containing 1 µCi of [γ-$#P]ATP ("5000 Ci}
mmol; Amersham) and 1 mM AMP}NDP as phosphate ac-
ceptors. The samples were rapidly centrifuged. Aliquots of the
supernatant were spotted on to Polygram CEL 300 PEI sheets
(Macherey-Nagel) and $#P-nucleotides were separated by TLC




(pH 3.5). At the same time, the cell pellet
was washed with RPMI 1640, boiled for 2 min with electro-
phoresis sample buffer [125 mmol}l Tris (pH 6.8), 4% SDS,
10% glycerol, 0.006% Bromophenol Blue, 2% 2-mercapto-
ethanol], and subjected to SDS}PAGE [15% (w}v) gel].
Generation of ecto-5«-nucleotidase polyclonal antibody and
immunoblotting
A peptide corresponding to residues "&&ETPFLSNPGTNLVF-
GD of the human ecto-5«-nucleotidase was synthesized, conju-
gated to keyhole-limpet (Diodora aspera) haemocyanin and used
for immunizations in rabbit. The serum obtained was tested with
ELISA by using purified human placental ecto-5«-nucleotidase
and further purified on a BSA-conjugated peptide affinity column
(SulfoLink Kit ; Pierce, Rockford, IL, U.S.A.). For Western-blot
analysis, the cells were incubated on ice for 10 min with lysis
buffer [10 mM Tris (pH 7.4)}0.15 M NaCl}5 mM EDTA}1%
(v}v) Triton X-100}5 µM dithiothreitol}100 µM PMSF], boiled
for 5 min with electrophoresis sample buffer, and subjected
to SDS}PAGE (8% gel). After transfer of separated proteins to
nitrocellulose membranes and blocking with PBS containing 5%
skimmed milk and 0.2% Tween 20, ecto-5«-nucleotidase was
detected by using purified rabbit antibody (0.1 µg}ml). The
bands were visualized using horseradish peroxidase-labelled anti-
rabbit Ig (Dako) and an ECL2 detection kit (Amersham).
Quantification of extracellular ATP level
Lymphoid cells (1¬10'}well) were incubated in 24-well plates in
the starting volume of 0.5 ml of RPMI 1640 in the absence or
presence of ADP}ITP. Subsamples of the medium (50 µl) were
periodically collected and assayed for ATP concentration by
luciferin–luciferase luminometry (Labsystems Luminoscan
1.2–0), as described previously [22].
Radioligand-binding studies
The uptake of [$H]adenosine into the cells was evaluated using
a high-speed filtration technique. Jurkat (1¬10& cells) and
Namalwa (5¬10& cells) were suspended in 200 µl of RPMI 1640,
containing 10 µmol}l inhibitor of adenosine deaminase erythro-
9-(2-hydroxy-3-nonyl)adenine hydrochloride (EHNA; Calbio-
chem, La Jolla, CA, U.S.A.) and pre-incubated for 20 min at
37 °C with or without the inhibitors of nucleoside transport
nitrobenzylthioinosine (NBTI) or dipyridamole (10 µmol}l ;
Sigma). The association reaction was started by the addition of
10 nmol}l [$H]adenosine and terminated at the desired time by
the addition of 3 ml of PBS followed by rapid filtration through
Whatman GF}C filters. Subsequent to washing twice, radio-
activity of the filters was measured in a liquid-scintillation
β-spectrometer (Wallac-1409). All values were corrected for
non-specific [$H]adenosine binding measured in the presence of
50 µmol}l unlabelled adenosine and it was no more than 15–20%
of the total radioligand binding.
Statistics
Statistical comparisons were made using Student’s t test, and
P! 0.05 was taken as significant. Data from kinetic experiments
were subjected to computer analyses using the Michaelis–Menten





analyses were performed using GraphPad PrismTM (version 3.0;
San Diego, CA, U.S.A.).
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RESULTS
Extracellular hydrolysis of 3H-nucleotides
Nucleotidase activities were determined by TLC as the rate of
$H-nucleotides conversion into dephosphorylated $H-metabolites
(e.g. pooled ADP, AMP and nucleoside fractions in the case of
[$H]ATP hydrolysis). Both intact cells and their sonicated lysates
were used as enzyme sources, thus allowing us to evaluate the
contribution of surface-associated ecto-nucleotidases to the total
pool of cellular nucleotidases. Based on the preliminary kinetic
studies [15], all nucleotide substrates were used at saturating
concentrations that considerably exceeded the K
m
(app) values
for the corresponding nucleotidases.
Figure 1 shows the rates of [$H]ATP (Figure 1A) and [$H]ADP
(Figure 1B) hydrolysis by endothelial and lymphoid cells. Among
the cells used, HUVEC exhibited the highest NTPDase activities,
with [$H]ADP being the preferential substrate. Relatively low
nucleotidase activities were observed in the experiments with
Namalwa and, especially, Jurkat cells. Furthermore, ATP- and
ADP-hydrolysing activities were increased by approx. 3- and 6-
fold respectively after disruption of lymphoid cells, suggesting
that these nucleotidases are primarily located intracellularly
rather than on the lymphoid surface. The AMP that is generated
in the course of NTPDase reaction can be further degraded to
adenosine by another ectoenzyme 5«-nucleotidase [8]. Use of
[$H]AMP as initial substrate revealed that HUVEC successfully
hydrolysed AMP (although not as efficiently as ATP}ADP),
whereas no adenosine formation was detected in the exper-
iments with lymphoid cells (Figure 1C). We also measured
the major ecto-nucleotidase activities in freshly isolated PBL
and detected relatively low rates of [$H]AMP hydrolysis
(8.4³0.8 nmol [ 10' cells−" [h−" ; n¯ 30) as compared with
[$H]ATP (29.4³3.8 nmol [ 10' cells−" [h−" ; n¯ 14).
Figure 1 Nucleotide-hydrolysing activities in HUVEC and lymphoid cells
Intact cells (black bars) and their sonicated lysates (white bars) were incubated for 60 min with
800 µmol/l [3H]ATP (A), 800 µmol/l [3H]ADP (B) and 300 µmol/l [3H]AMP (C). The ordinate
shows enzymic activities expressed as nmol of 3H-nucleotides dephosphorylated by 106 cells/h
(means³S.E.M. ; n ¯ 4–5). ND, not detectable. *P ! 0.05 for cell lysates as compared with
the enzyme activities of intact cells.
Figure 2 Ecto-5«-nucleotidase/CD73 expression on endothelial and lymph-
oid cells
Fluorescence histograms of HUVEC (A) and Jurkat cells (B) after incubation with an anti-CD73
mAb 4G4 (bold line) and with a negative control mAb 3G6 (thin line). CD73 expression was
also detected after HUVEC treatment with 0.5 unit/ml PI-PLC (dotted line). Data are plotted as
cell number versus fluorescence intensity. (C) Western-blot analysis of ecto-5«-nucleotidase
expression in HUVEC, lymphoid cell lines Namalwa and Jurkat, as well as PBL lysates isolated
from two different donors. Note that the amount of the protein loaded in the case of HUVEC
and lymphocytes was equal to 15 and 50 µg respectively.
Since ecto-5«-nucleotidase activity on various lymphoid cell
types has been shown to be attributed to the surface antigen
CD73 [23], the relationship between ecto-5«-nucleotidase
and CD73 molecules on the endothelial surface is revealed. Flow-
cytometric analysis showed high expression of CD73 molecules
on HUVEC surface (Figure 2A) and the complete CD73 nega-
tivity of Jurkat (Figure 2B) and Namalwa cells (results not
shown). Treatment of the HUVEC with PI-PLC caused cleavage
of the most glycosylphosphatidylinositol-anchored CD73
molecules and reduced the number of CD73-positive cells from
87³5% (n¯ 7) to 26³3% (n¯ 4) (Figure 2A). Concurrent
measurement of the rate of [$H]AMP hydrolysis revealed the
proportional decrease of 5«-nucleotidase activity in PI-PLC-
treated HUVEC by at least 75–80% (results not shown),
confirming the existence of single endothelial 5«-nucleotidase}
CD73 molecule sharing both enzymic and antigenic properties.
Cell-surface expression of ecto-5«-nucleotidase}CD73 was
further analysed by immunoblotting analysis with newly de-
veloped anti-ecto-5«-nucleotidase polyclonal antibody. A single
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Figure 3 Pattern of AMP metabolism on the cell surface
(A) Namalwa cells were incubated with 10 µmol/l [3H]AMP in the absence (E) and presence
of 300 µmol/l ATP (+) or 50 µmol/l Ap5A (D). The cells were also pretreated with apyrase
(2 units/ml), washed and challenged with [3H]AMP (*). The ordinate shows the amount of
[3H]AMP converted into [3H]ADP/ATP (µmol/l). (B) Namalwa (^) and Jurkat cells (_) were
incubated with 1 mmol/l ATP in the presence of the indicated concentrations of [3H]AMP. The
ordinate shows adenylate kinase activity expressed as nmol of [3H]ADP/ATP formed by
106 cells/min. (C) HUVEC (HUV) and Namalwa cells (Nam) were incubated for 30 min with
10 µmol/l [3H]AMP in the absence and presence of 300 µmol/l ATP and 50 µmol/l Ap5A, as
indicated. [3H]AMP and its 3H-derivatives, ATP, ADP, adenosine (Ado), hypoxanthine (Hyp) and
inosine (Ino) were separated by TLC and developed by autoradiography. Note that the amount
of radioactivity in this particular illustrative experiment was 10 times higher (approx.
4¬105 d.p.m./spot) than that used in the quantitative assays with scintillation β-counting.
protein band of approx. 70 kDa was clearly detected in HUVEC,
but not in Jurkat and Namalwa cells (Figure 2C). Only a slight
expression of ecto-5«-nucleotidase was detected in PBL lysates
(Figure 2C), and these findings are consistent with previous
results that only 11–14% of circulating lymphocytes are CD73-
positive [21,23].
Transphosphorylation of 3H-labelled and unlabelled nucleotides
Namalwa cells were unable to degrade [$H]AMP, but, instead,
converted its minor part into $H-labelled high-energy
phosphoryls (Figure 3A). Removal of extracellular ATP pool by
soluble apyrase did not affect this reverse reaction, whereas
specific adenylate kinase inhibitor Ap
&
A prevents [$H]AMP
phosphorylation. Addition of exogenous ATP dramatically activ-
ated [$H]AMP phosphorylation in these cells (Figure 3A), and
a similar pattern of nucleotide metabolism was observed with
another lymphoid cell line, Jurkat T-cells. The concentration–
Figure 4 Nucleotide kinase activities in endothelial and lymphoid cells
HUVEC (A), Namalwa (B) and Jurkat cells (C) were incubated with [3H]AMP (400 µmol/l ;
45 min) or [3H]ADP (800 µmol/l ; 15 min) in the presence of 1 mmol/l ATP/NTP as phosphate
donors. The ordinate shows enzymic activities expressed as nmol of 3H-nucleotides
phosphorylated by 106 cells/h (means³S.E.M. ; n ¯ 4–8). Similar assays were performed
with equivalent amounts of the sonicated lysates (white bars), and asterisks indicate their
significant deviation from the corresponding activities of intact cells (P ! 0.05).
response curves were then generated under conditions that
approximated first-order rates of the reaction, i.e. one substrate
was maintained at saturating concentration (ATP; 1 mM) and
the concentration of another substrate [$H]AMP was varied
(Figure 3B). Statistical analyses revealed that the V
max
value for
adenylate kinase reaction in Namalwa is approx. 3-fold higher
than that of Jurkat cells (170³6 and 58³4 nmol [ 10' cells−" [h−"
respectively), whereas the K
m
values for both cell types are
comparable and vary within 50–60 µmol}l range.
While these results are principally consistent with coexistence
of two opposite, ATP-consuming and ATP-generating, pathways
on HUVEC surface [15], there are some clear-cut differences
between endothelial and lymphoid cell types. As can be seen in
Figure 3(C), addition of [$H]AMP to the HUVEC caused its
conversion into [$H]nucleosides (lane 2), whereas Namalwa cells
were unable to degrade [$H]AMP (lane 3). Both lymphoid (lane
5) and endothelial (lane 6) cells caused significant ATP-mediated
[$H]AMP phosphorylation. However, Namalwa cells con-
verted [$H]AMP into [$H]ADP even in the absence of exogenous
ATP (lane 3), and this reaction was prevented by Ap
&
A (lane 4).
For quantitative analysis, the cells were then incubated with
[$H]AMP and ATP at concentrations that significantly exceeded
the K
m
values for adenylate kinases in lymphoid cells (see Figure
3B) and HUVEC [15]. All cells caused specific ATP-dependent
[$H]AMP phosphorylation, and it was significantly increased
after disruption of the cells (Figure 4). Significant adenylate
kinase activity was also detected in PBL suspensions
(30.6³4.6 nmol [ 10' cells−" [h−" ; n¯ 8), which increased by
50–60% after lymphocyte sonication. The ADP that is generated
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Figure 5 Bioluminescent determination of extracellular ATP
(A) Jurkat (D) and Namalwa cells (E) were incubated in the 24-well plates, and aliquots of
the medium were assayed for ATP. Jurkat (^) and Namalwa (_) cells were also pretreated
with apyrase (2 units/ml), washed and assayed for ATP. (B) The ATP level was measured after
30 min incubation of Jurkat (white bars) and Namalwa (black bars) with the indicated
concentrations of exogenous nucleotides (µmol/l). Note that the ordinate panel represents the
logarithmic scale of ATP concentration. All values are means³S.E.M. for at least three
independent experiments.
in the course of adenylate kinase reaction can be further converted
into ATP by ecto-NDP kinase [15], and this enzymic activity was
measured with [$H]ADP as an initial substrate. Unlike [$H]AMP
phosphorylation, subsequent [$H]ADP conversion into [$H]ATP
is characterized by a much higher rate, is predominantly localized
on the cell surface and can be activated not only by ATP but also
by other γ-phosphate-donating NTPs (Figure 4).
Bioluminescent determination of extracellular ATP synthesis
To determine whether phosphoryl transfers can directly regulate
the extracellular ATP level, we employed a luciferin–luciferase
assay, which is highly sensitive and specific for ATP. In the
absence of any treatment, the amount of ATP in the incubation
medium with lymphoid cells is maintained at a certain steady-
state level that can be depleted by pretreatment of the cells with
apyrase (Figure 5A). Addition of 10–20 µmol}l ADP to the
lymphocytes activated reverse adenylate kinase reaction with a
corresponding progressive ATP formation (Figure 5B), and it
can be blocked by specific adenylate kinase inhibitor Ap
&
A
(10 µmol}l). Addition of ADP in combination with ITP (Figure
5B) or other nucleotides, GTP and UTP (results not shown),
induced even more pronounced ATP synthesis, thus confirming
the necessity of a γ-phosphate donating NTP for efficient ADP
conversion into ATP via ecto-NDP kinase reaction.
Metabolism of [γ-32P]ATP and ecto-protein phosphorylation
Nucleotide kinase-mediated phosphotransfers were independ-
ently measured by using [γ-$#P]ATP. Incubation of Namalwa
cells with [γ-$#P]ATP in the presence of 1 mmol}l AMP or NDPs
caused a direct transfer of the γ-terminal [$#P]phosphate with the
Figure 6 Transfer of γ-phosphate from [γ-32P]ATP
Namalwa cells were incubated for 5 min with [γ-32P]ATP in the absence (contr) and presence
of 1 mmol/l AMP/NDP, as indicated. The cells were sedimented by centrifugation. Aliquots of
the supernatant were loaded on to TLC plate with subsequent nucleotide separation (A),
whereas the pellets were lysed and equal amounts of the cell protein were loaded and subjected
to SDS/PAGE (15% gel) (B). Molecular-mass marker sizes (kDa) are indicated on the left (B).
The last lane on autoradiography in (A) shows the purity of [γ-32P]ATP in the absence of the
cells.
formation of the corresponding [$#P]ADP}NTP (Figure 6A). To
test whether plasma membrane proteins can be phosphorylated
under these conditions, the cell pellet was washed and subjected
to SDS}PAGE. Incorporation of radioactivity into proteins was
observed following incubation of [γ-$#P]ATP with Namalwa cells
(Figure 6B), but not HUVEC or Jurkat cells (results not shown),
with one approx. 20 kDa substrate being the major labelled
protein. Addition of AMP and, especially, ADP}UDP together
with [γ-$#P]ATP decreased protein phosphorylation with con-
current activation of phosphotransfers (Figure 6). Pretreatment
of the cells with low concentrations of trypsin (0.5 µg or
7.2 units}sample) also markedly decreased the incorporation of
radioactivity into this 20 kDa protein (results not shown),
suggesting the cell-surface origin of this phosphoprotein.
Adenosine deaminase activity in endothelial and lymphoid cells
Adenosine deaminase was determined by [$H]adenosine con-
version into $H-labelled inosine and hypoxanthine. Substrate
concentration was chosen to be 10 times that of the K
m
values
(approx. 70–80 µmol}l) for adenosine deaminases found in the
studied lymphoid cells (results not shown) and other cell types
[11]. The highest [$H]adenosine deamination was observed in the
experiments with Jurkat cells, which exceed the enzyme activities
on HUVEC and Namalwa cells by 10- and 6-fold respectively
(Figure 7). This reaction was inhibited by approx. 90% in the
presence of adenosine deaminase inhibitor EHNA. Whereas
disruption of the cells did not induce significant increases in the
measured enzyme activities (Figure 7), such a comparative
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Figure 7 Adenosine deaminase activity in endothelial and lymphoid cells
HUVEC (A), Namalwa (B) and Jurkat cells (C) were incubated with [3H]adenosine (800 µmol/l ;
60 min) and the enzyme activity was determined by the formation of 3H-labelled inosine/
hypoxanthine. The experiments were performed with intact cells (black bars) or their sonicated
lysates (white bars). The inhibitors of nucleoside transport (5 µmol/l NBTI) or adenosine
deaminase (2.5 µmol/l EHNA) were added to the cells 20 min prior to the addition of
[3H]adenosine. *P ! 0.05 for NBTI- or EHNA-treated cells as compared with the corresponding
activities of non-treated cells. **P ! 0.05 for cell lysates as compared with intact cells both
measured under the inhibition of adenosine transport by NBTI.
Figure 8 Time course of [3H]adenosine binding to the lymphoid cells
Namalwa (A) and Jurkat (B) cells were incubated with 10 nmol/l [3H]adenosine in the absence
(filled symbols) and presence (open symbols) of the inhibitor of nucleoside transport NBTI
(10 µmol/l). Association reaction was terminated at the indicated time points by rapid filtration
of the mixture through Whatman GF/C filters. The amount of the cell-associated ligand is
expressed on the ordinate as fmol of [3H]adenosine per 106 cells. All samples contained
10 µmol/l EHNA. The graphs show mean data of two independent experiments, the results of
which differed by less than 10%.
analysis is complicated by the alternative mechanism of
nucleoside transport into the intact cells with subsequent intra-
cellular deamination [13].
For direct evaluation of the extent of [$H]adenosine uptake we
applied the high-speed filtration technique. In order to avoid
undesirable radioligand deamination, adenosine deaminase in-
hibitor EHNA was included in the assay buffer. [$H]Adenosine
binds to Namalwa cells with a pronounced lag period, and the
amount of cell-associated radioligand was significantly decreased
in the presence of NBTI (Figure 8A) or dipyridamole (results not
shown). Contrary to Namalwa, Jurkat cells were characterized
by a distinct association pattern manifested in the immediate
[$H]adenosine binding, about 7 times higher than the ligand-
binding capacity, and insensitivity to NBTI treatment (Figure
8B). Comparison of these radioligand-binding results with
enzymic results on [$H]adenosine deamination by intact and
disrupted cells measured in the presence of NBTI (see Figure 7)
suggests that in the case of Namalwa cells (and presumably,
HUVEC) most of the adenosine is transported via equilibrative
nucleoside carriers with subsequent intracellular deamination,
whereas an alternative inactivating mechanism via ecto-
adenosine deaminase reaction prevails on the Jurkat surface.
DISCUSSION
This work was designed to evaluate the metabolism of exogenous
purines by endothelial and lymphoid cells, and in this way to
characterize the main ectoenzymic activities that govern the
duration and magnitude of purinergic signalling in the vascu-
lature. The following three groups of cell surface-associated
enzymes were identified: nucleotide hydrolases, nucleotide
kinases and adenosine deaminase. These pathways are schematic-
ally illustrated in Scheme 1.
The extracellular elements of the nucleotide-inactivating cas-
cade that include endothelial NTPDases (otherwise known
as ecto-ATPase, ATPDase, apyrase, CD39) and ecto-5«-
nucleotidase}CD73 are considered to form the major effector
system terminating purinergic effects of ATP}ADP in the blood-
stream [24–26]. The present work, when analysed together with
our previous studies [15,22], confirms the existence of high
ATP}ADP-hydrolysing activities on HUVEC surface that seems
to be mediated by a single ectoenzyme with hallmark charac-
teristics of dedicated NTPDase-1 [9]. Further, AMP hydrolysis
on the HUVEC surface is mediated by glycosylphosphatidyl-
inositol-anchored ectoenzyme 5«-nucleotidase}CD73 with mol-
ecular mass of approx. 70 kDa, as verified here by its shedding
from the cell surface under treatment with PI-PLC, positive
staining with anti-CD73 mAbs and Western blotting with a
newly developed anti-ecto-5«-nucleotidase antibody. In contrast
Scheme 1 Ectoenzymic purine turnover on the cell surface
The scheme shows the potential exchange activities of extracellular nucleotides as well as their
conversion into adenosine (Ado), inosine (Ino) and hypoxanthine (Hyp). (1) NTPDase/CD39 (EC
3.6.1.5) ; (2) ecto-5«-nucleotidase/CD73 (EC 3.1.3.5) ; (3) adenosine deaminase (EC 3.5.4.4) ; (4)
adenylate kinase (EC 2.7.4.3) ; (5) NDP kinase (EC 2.7.4.6). Vertical dashed arrows and blunted
line depict activating and inhibiting regulatory mechanisms respectively.
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with endothelial cells with their high capacity to dispose of extra-
cellular nucleotides, the very low (or even undetectable) activities
of ecto-5«-nucleotidase}CD73 and NTPDase}CD39 have been
described on various cell types of haematopoietic origin
[3,24,27,28]. Our present findings with lymphoid cell lines and
freshly isolated PBL are consistent with these observations.
The fate of the nucleotide-derived adenosine is defined by
its uptake into the cell [13] followed by either phosphorylation
to AMP via an adenosine kinase reaction or deamination to
inosine by intracellular adenosine deaminase [11,29,30]. An
alternative mechanism of adenosine deaminase anchorage to the
plasma membrane via association with lymphocyte activation
antigen CD26}dipeptidyl peptidase IV or adenosine receptors
has also been demonstrated by using confocal microscopy, co-
immunoprecipitation and radioligand-binding studies [31–33]. In
particular, co-localization of adenosine deaminase and adenosine
A
#B
receptor has been shown recently for Jurkat T-cells [32] and
our results confirmed the abundant expression of ecto-adenosine
deaminase on the surface of Jurkat and, to a lesser degree,
HUVEC and Namalwa cells. Furthermore, in the present study,
we show that this extracellular protein is enzymically active and
can be implicated, along with nucleoside transporters, in purine
turnover via inactivation of external adenosine directly on the
cell surface.
Along with the commonly accepted view of extracellular
nucleotide degradation cascade as a purine-inactivating mech-
anism relevant for the function of purinergic receptors, an
opposite ATP-generating pathway via phosphotransfer reactions
has been only recently appreciated [14–16]. The results in the
present study, together with previous competitive and substrate-
specificity studies [14–16], demonstrate the expression of ecto-
adenylate kinase and NDP kinase activities on the surface of
endothelial and lymphoid cells. In combination, these extra-
cellular enzymic activities would serve an anabolic purpose and
maintain specific concentrations of extracellular nucleotides.
Direct measurement of ATP concentration by a luciferin–
luciferase assay revealed that lymphocytes maintain extracellular
ATP at certain steady-state nanomolar level that represents a net
balance between constitutive ATP release, and its subsequent
hydrolysis and}or interconversion [34]. Furthermore, the fact
that [$H]AMP phosphorylation in Namalwa cells occurs even in
the absence of exogenous γ-phosphate-donating ATP and was
not eliminated after ATP scavenging by soluble apyrase suggests
that there may be transient and local formation of relatively high
(micromolar) ATP concentrations that are resistant to apyrase
and different from the ‘bulk’ extracellular ATP pools. A similar
observation has been shown previously with firefly luciferase
stably adsorbed on the platelet surface [35].
We also found preferential labelling of a cell-surface-associated
approx. 20 kDa substrate after the addition of [γ-$#P]ATP to the
Namalwa cells, but not Jurkat and HUVEC. Combined exposure
of the cells to ATP and other nucleotides significantly inhibited
ecto-protein phosphorylation with concurrent activation of
phosphotransfer reactions. These findings indicate that, in add-
ition to serving as a substrate for ecto-nucleotide kinases, ATP
can also be utilized by ecto-protein kinases and further suggest
the existence of a certain competition between these ectoenzymic
pathways. While the phosphorylation of cell-surface proteins
and their involvement in cell–cell contacts, platelet function,
cellular differentiation and proliferation are being studied
vigorously [17], further studies are required to elucidate the
physiological role of ecto-protein kinases and the nature of
the phosphorylated proteins.
In conclusion, in the present work, we demonstrate the
coexistence of two opposite ectoenzymic pathways on the cell
surface, where constitutive ATP release, continuous re-synthesis
of high-energy phosphoryls and selective ecto-protein
phosphorylation are counteracted by stepwise nucleotide break-
down with subsequent nucleoside inactivation. Given that ecto-
5«-nucleotidase catalyses the irreversible step of AMP conversion
into adenosine and is strongly inhibited by precursor ADP}ATP
[15,25], the specific ratios of nucleoside mono-, di-, and tri-
phosphates determine the shift towards nucleotide synthesis or
degradation. Either direction may be locally influenced by a
specific enzymic make-up or by physiological circumstances.
Moreover, taking into account the ability of NDP kinase to use
indifferently all naturally occurring ribonucleotides, one might
suggest that the crucial role of this ectoenzyme is the directional
switch between various purine and pyrimidine receptors via
rapid interconversion of the circulating NTP}NDP.
The relative activities of purine-converting ectoenzymes vary
dramatically among endothelial and lymphoid cells, and these
findings are particularly pertinent in this context, with divergent
effects of ATP and adenosine in the vasculature [4,6]. In this
scenario, the cells with high NTPDase and ecto-5«-nucleotidase
activities, such as vascular endothelium, tend to compensate
pro-inflammatory and pro-thrombotic effects of circulating
ATP}ADP with respective generation of anti-inflammatory
agent adenosine. In contrast, the lymphoid cells with low or
no ecto-nucleotidase activities and a relatively high expression of
ecto-adenosine deaminase are characterized by ‘ATP-generating}
adenosine-eliminating’ phenotype, thus allowing them to avoid
lymphotoxic effects of adenosine, impair endothelial barrier
function and propagate ATP-mediated signalling effects to the
endothelial cells.
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